The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial is a research paper published in Clinical Infectious Diseases (2023). On theSindex it has a DataRank of 0.603. It has been cited 16 times, with 9 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0.178
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 9 citers.
Clinical and Translational Science Awards
Grant: UL1TR000445
NIAID NIH HHS
Grant: U01 AI125135
NIAID NIH HHS
Grant: P30 AI110527
NCATS NIH HHS
Grant: UL1 TR002243
National Institutes of Health
Grant: 5U01AI125135-02
Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients
National Institutes of Health
Grant: 5UL1TR002243-05
Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 6UL1TR000445-11
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
NIH
National Institute of Allergy and Infectious Diseases
FWCI
2.88
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals